Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02243241Phase 1Completed
Phase 1, randomised, double-blind trial of hydrocodone in pain (3 arms), sponsored by Purdue Pharma. Primary endpoint: Time-matched analysis on QT data corrected for heart rate based on an individual correction method at Day 15. Started Nov 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02243241.